IPR News

EPO Practices and Procedures in the Field of Pharmaceuticals and Biotechnology - EPO seminar for Patent Attorneys, New Delhi

1

The European Business and Technology Centre (EBTC) and the European Patent Office (EPO) co-organised a focused seminar on “EPO Practices and Procedures in the Field of Pharmaceuticals and Biotechnology”, in New Delhi on 27th March 2017. The event was specifically designed for IP practitioners and industry experts based in Delhi and the National Capital Region (NCR). It put a special focus on the European practices in the pharmaceutical and biotechnology domain.

          

The presentations were followed by a very interactive discussion. The participants expressed in particular the need to increase awareness about the EPO Guidelines for Examination as well as the instructions on the practices and procedures which are followed in the various aspects of the examination.
After a welcome address by Mr. Poul Jensen, EBTC Director, the leading EPO experts on the subject matter, Dr. A. Stamatopoulos, Principal Director Biotechnology / PAOC, Dr. Dieter Tzschoppe, Director Pharmaceuticals, and Mr. Klaus-Peter Döpfer, Director Biotechnology, gave three very insightful presentations on latest developments at the EPO, patentable  and non-patentable subject matter in the fields of pharmaceuticals and biotechnology  including   procedural and patentability aspects of the grant and opposition      procedure at the EPO for applications and patents relating to pharmaceuticals and biotechnology.

 

The event was attended by 32 senior representatives from law firms and IP counsellors.

 

         Group photo of the seminars attendees

The seminar’s content and the efforts by the EPO have been very much appreciated by the participants and the law firms they represent. They expressed the wish to organise further seminars of this kind with a clear focus on specific domains in the future.

The seminar was organized within the frame of the EPO/EBTC activities in Indo-European cooperation for intellectual property rights (IPR), as EBTC is the official implementation partner of the European Patent Office (EPO) in India.

Protecting pharmaceuticals and biotechnology inventions in Europe

1

In view of the changing scenario of IP in India and the increasing number of international patent filings by Indian biotech and pharma companies, IP practitioners and experts, whether in private practice or industry, should be familiar with the latest developments at the EPO – the patent office for Europe - as far as filing, prosecution and examination procedures and practices in the field of pharma/biotech are concerned.

The seminar will provide a unique opportunity to gain a deep insight into the Pharma/Biotech practice in Europe and to interact with leading EPO experts on the subject matter, in particular Dr. A. Stamatopoulos, Principal Director Biotechnology / PAOC, Dr Dieter Tzschoppe, Director Pharma, and Mr. Klaus-Peter Döpfer, Director Biotechnology.

The event is co-organised by the European Business Technology Centre (EBTC), the European Patent Office (EPO) and the Association of Biotechnology-Led Enterprises (ABLE)

There is no registration fee, but places are limited, and we would therefore appreciate to receive your nominations by return e-mail before 10 March on This email address is being protected from spambots. You need JavaScript enabled to view it. .

EPO practices and procedures in the field of pharmaceuticals and biotechnology

1

In view of the changing scenario of IP in India and the increasing number of international patent filings by Indian residents, IP practitioners in India, whether in private practice or industry, should be familiar with the latest developments at the EPO – the patent office for Europe - as far as filing, prosecution and examination procedures and practices in the field of pharma/biotech are concerned.

The seminar will provide a unique opportunity to gain a deep insight into the Pharma/Biotech practice of the EPO and to interact with leading EPO experts on the subject matter, Dr. A. Stamatopoulos, Principal Director Biotechnology / PAOC, Dr. Dieter Tzschoppe, Director Pharma, and Mr. Klaus-Peter Döpfer, Director Biotechnology.

The event is co-organised by the European Business Technology Centre (EBTC) and the European Patent Office (EPO).

Additional information